TrialThe pharmacogenomics journal

Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence.

J P Dahl et al.PubMed ↗Publisher ↗

No numbers read from the abstract.